Jeff Duan
Directeur Général chez PharmaLegacy Laboratories (Shanghai) Co., Ltd.
Provenance du réseau au premier degré de Jeff Duan
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
 PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China.
13
| Holding Company | Miscellaneous Commercial Services | 13 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Jeff Duan via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| Tongji University | College/University | Corporate Officer/Principal Graduate Degree | |
| CELLULAR BIOMEDICINE GROUP, INC. | Biotechnology | Director/Board Member | |
| Shanghai International Studies University | College/University | Graduate Degree | |
| Yale University | College/University | Graduate Degree | |
| Stanford University | College/University | Graduate Degree | |
Genor Biopharma Co., Ltd.
 Genor Biopharma Co., Ltd. BiotechnologyHealth Technology Genor Biopharma Co., Ltd. engages in the manufacture and development of antibodies and related biological products. Its business scope includes research and development of monoclonal antibodies and biological products; research and development of instruments, equipment and reagents related to monoclonal antibodies and biological products; and wholesale, import and export of instruments, mechanical equipment, pharmaceutical equipment, and pharmaceutical intermediates. The company was founded on December 4, 2007 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member | |
| SUZHOU NANOMICRO TECHNOLOGY CO., LTD. | Miscellaneous Commercial Services | Director/Board Member | |
| GEMPHARMATECH CO., LTD. | Biotechnology | Director/Board Member | |
| Indiana University | College/University | Masters Business Admin | |
| China Pharmaceutical University | College/University | Graduate Degree | |
| The University of Waterloo | College/University | Undergraduate Degree | |
| Shanghai Panxin Equity Investment Management Co. Ltd. | Chief Investment Officer | ||
| Hebei University of Technology | College/University | Masters Business Admin | |
| Shanghai University | College/University | Undergraduate Degree | |
| Université Pierre-Mendès-France | College/University | Masters Business Admin | |
| Shanghai Institute of Pharmaceutical Industry | College/University | Graduate Degree | |
| Australian National University | College/University | Graduate Degree | |
| Nanjing University | College/University | Graduate Degree | |
| The Hong Kong University of Science & Technology | College/University | Undergraduate Degree | |
| ZHAOKE OPHTHALMOLOGY LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Citigroup Global Markets Asia Ltd.
 Citigroup Global Markets Asia Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Asia Ltd. (CGMA) is a securities brokerage firm headquartered Hong Kong. They are a subsidiary of Citigroup Global Markets Hong Kong Holdings Ltd., ultimately owned by Citigroup, Inc. (NYSE: C) in the US. Formerly known as Citi Smith Barney, the firm was reorganized in 2008 when Citigroup combined their brokerage and private banking businesses. CGMA offers stock trading services to various institutional investors. | Investment Banks/Brokers | Corporate Officer/Principal | |
Elpiscience Biopharma Ltd.
 Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of North Texas Health Science Center | College/University | Doctorate Degree | |
| Peking Union Medical College | College/University | Doctorate Degree | |
| Chinese Academy of Medical Sciences | College/University | Doctorate Degree | |
| Harbin Medical University | College/University | Undergraduate Degree | |
| ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD. | Pharmaceuticals: Major | Director/Board Member | |
| GUANGZHENG EYE HOSPITAL GROUP CO.,LTD. | Medical/Nursing Services | Director/Board Member | |
| GRACELL BIOTECHNOLOGIES INC. | Biotechnology | Director/Board Member | |
| LEGEND BIOTECH CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| Temple University School of Medicine | College/University | Corporate Officer/Principal | |
LAV Management Co., Ltd.
 LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Investment Managers | Corporate Officer/Principal | |
| The BayHelix Group | Director/Board Member | ||
| China Medical University | College/University | Graduate Degree | |
| The University of Sheffield | College/University | Graduate Degree | |
| The University of Chicago | College/University | Masters Business Admin | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| GENOR BIOPHARMA HOLDINGS LIMITED | Biotechnology | Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree |
Statistiques
Internationale
| Chine | 19 |
| Etats-Unis | 11 |
| Hong Kong | 4 |
| Îles Cayman | 4 |
| Royaume-Uni | 3 |
Sectorielle
| Consumer Services | 24 |
| Health Technology | 11 |
| Finance | 3 |
| Commercial Services | 2 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 22 |
| Graduate Degree | 10 |
| Independent Dir/Board Member | 8 |
| Corporate Officer/Principal | 7 |
| Doctorate Degree | 4 |
Relations les plus connectées
| Insiders | |
|---|---|
| Guo Tong Xu | 11 |
| Yu Chen | 11 |
| Xiao Hui Ji | 9 |
| Wen Jun Zhu | 3 |
| Jun Yi Li | 3 |
| Xin Huang | 2 |
| Jun Li | 2 |
| Xin Shu | 2 |
| Sheng Xue Mou | 2 |
| Zi Chun Ding | 2 |
| Yue Chi Zhang | 2 |
| Xiao Kang Liu | 2 |
| Xu Chen Duan | 2 |
